Microdosing

Microdosing is a practice that involves consuming small, sub-perceptual amounts of psychedelic substances, such as LSD or psilocybin mushrooms. The doses are typically around one-tenth to one-twentieth of a normal recreational dose. The aim of microdosing is not to induce a psychedelic experience, but rather to enhance creativity, productivity, and emotional balance.

History

The concept of microdosing has been around for several years, but it gained significant attention in the 21st century, particularly in the tech industry in Silicon Valley. The practice was popularized by James Fadiman, a psychologist and researcher who has been studying psychedelics since the 1960s.

Effects

Microdosing is believed to have several potential benefits, including increased creativity, improved focus and productivity, enhanced emotional balance, and reduced anxiety and depression. However, these effects are largely anecdotal and more scientific research is needed to confirm them.

Research

While there is a growing body of anecdotal evidence supporting the benefits of microdosing, scientific research in this area is still in its early stages. Some studies have suggested potential benefits, but more rigorous, controlled studies are needed to confirm these findings.

Risks and Controversies

Despite the potential benefits, microdosing also carries risks. These include potential legal issues, as many psychedelic substances are illegal in many jurisdictions. There are also potential health risks, including the possibility of triggering latent mental health issues.

See Also

• Psychedelic therapy
• Psychedelic drugs
• James Fadiman

References

This article is a stub related to pharmacology. You can help WikiMD by expanding it!